95 related articles for article (PubMed ID: 16532034)
1. Phosphorylation of the discs large tumour suppressor protein controls its membrane localisation and enhances its susceptibility to HPV E6-induced degradation.
Massimi P; Narayan N; Cuenda A; Banks L
Oncogene; 2006 Jul; 25(31):4276-85. PubMed ID: 16532034
[TBL] [Abstract][Full Text] [Related]
2. The high-risk HPV E6 oncoprotein preferentially targets phosphorylated nuclear forms of hDlg.
Narayan N; Subbaiah VK; Banks L
Virology; 2009 Apr; 387(1):1-4. PubMed ID: 19307009
[TBL] [Abstract][Full Text] [Related]
3. High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines.
García-Alai MM; Dantur KI; Smal C; Pietrasanta L; de Prat-Gay G
Biochemistry; 2007 Jan; 46(2):341-9. PubMed ID: 17209544
[TBL] [Abstract][Full Text] [Related]
4. HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase.
Pim D; Thomas M; Javier R; Gardiol D; Banks L
Oncogene; 2000 Feb; 19(6):719-25. PubMed ID: 10698489
[TBL] [Abstract][Full Text] [Related]
5. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
6. Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes.
Watson RA; Thomas M; Banks L; Roberts S
J Cell Sci; 2003 Dec; 116(Pt 24):4925-34. PubMed ID: 14625386
[TBL] [Abstract][Full Text] [Related]
7. E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway.
Contreras-Paredes A; De la Cruz-Hernández E; Martínez-Ramírez I; Dueñas-González A; Lizano M
Virology; 2009 Jan; 383(1):78-85. PubMed ID: 19007961
[TBL] [Abstract][Full Text] [Related]
8. HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation.
Massimi P; Gammoh N; Thomas M; Banks L
Oncogene; 2004 Oct; 23(49):8033-9. PubMed ID: 15378012
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.
Thatte J; Banks L
J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500
[TBL] [Abstract][Full Text] [Related]
10. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6.
Lichtig H; Algrisi M; Botzer LE; Abadi T; Verbitzky Y; Jackman A; Tommasino M; Zehbe I; Sherman L
Virology; 2006 Jun; 350(1):216-27. PubMed ID: 16519914
[TBL] [Abstract][Full Text] [Related]
11. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
[TBL] [Abstract][Full Text] [Related]
12. The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins.
Thomas M; Massimi P; Navarro C; Borg JP; Banks L
Oncogene; 2005 Sep; 24(41):6222-30. PubMed ID: 16103886
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the discs large tumour suppressor identifies domains responsible for human papillomavirus type 18 E6-mediated degradation.
Gardiol D; Galizzi S; Banks L
J Gen Virol; 2002 Feb; 83(Pt 2):283-289. PubMed ID: 11807220
[TBL] [Abstract][Full Text] [Related]
14. CDK phosphorylation of the discs large tumour suppressor controls its localisation and stability.
Narayan N; Massimi P; Banks L
J Cell Sci; 2009 Jan; 122(Pt 1):65-74. PubMed ID: 19066288
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation.
Gardiol D; Kühne C; Glaunsinger B; Lee SS; Javier R; Banks L
Oncogene; 1999 Sep; 18(40):5487-96. PubMed ID: 10523825
[TBL] [Abstract][Full Text] [Related]
16. HPV-16 E6 oncoprotein impairs the fidelity of DNA end-joining via p53-dependent and -independent pathways.
Shin KH; Ahn JH; Kang MK; Lim PK; Yip FK; Baluda MA; Park NH
Int J Oncol; 2006 Jan; 28(1):209-15. PubMed ID: 16327998
[TBL] [Abstract][Full Text] [Related]
17. HPV16 E6 Controls the Gap Junction Protein Cx43 in Cervical Tumour Cells.
Sun P; Dong L; MacDonald AI; Akbari S; Edward M; Hodgins MB; Johnstone SR; Graham SV
Viruses; 2015 Oct; 7(10):5243-56. PubMed ID: 26445057
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
Yugawa T; Kiyono T
Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
[TBL] [Abstract][Full Text] [Related]
19. HPV-16E6 can induce multiple site phosphorylation of p53.
Zhang G; Sun L; Li Z; Si L; Song T; Huang C; Zhang W
Oncol Rep; 2009 Feb; 21(2):371-7. PubMed ID: 19148510
[TBL] [Abstract][Full Text] [Related]
20. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
Seo SH; Jin HT; Park SH; Youn JI; Sung YC
Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
